Abiopharma

🔍 Simon Frederic (Executive)

Company: JFrog Ltd (FROG)

Report Date: 2026-06-01

Detailed Transactions and Holdings:

• Sold 4,800 shares of Ordinary Shares at $80.47 per share (Direct)
  Date: 2026-06-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,339,528.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 7,300 shares of Ordinary Shares at $81.65 per share (Direct)
  Date: 2026-06-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,332,228.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 6,052 shares of Ordinary Shares at $82.64 per share (Direct)
  Date: 2026-06-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,326,176.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 11,948 shares of Ordinary Shares at $83.5 per share (Direct)
  Date: 2026-06-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,314,228.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 8,450 shares of Ordinary Shares at $84.5 per share (Direct)
  Date: 2026-06-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,305,778.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 4,179 shares of Ordinary Shares at $85.81 per share (Direct)
  Date: 2026-06-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,301,599.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 38,784 shares of Ordinary Shares at $86.76 per share (Direct)
  Date: 2026-06-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,262,815.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 22,436 shares of Ordinary Shares at $87.62 per share (Direct)
  Date: 2026-06-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,240,379.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 16,051 shares of Ordinary Shares at $88.3 per share (Direct)
  Date: 2026-06-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,224,328.00 | transaction_form_type: 4 | Footnotes: F1, F10

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2025.
• F2: This transaction was executed in multiple trades at prices ranging from $80.05 to $81.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F3: This transaction was executed in multiple trades at prices ranging from $81.07 to $82.04. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F4: This transaction was executed in multiple trades at prices ranging from $82.09 to $83.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F5: This transaction was executed in multiple trades at prices ranging from $83.09 to $84.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F6: This transaction was executed in multiple trades at prices ranging from $84.09 to $84.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F7: This transaction was executed in multiple trades at prices ranging from $85.13 to $86.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F8: This transaction was executed in multiple trades at prices ranging from $86.13 to $87.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F9: This transaction was executed in multiple trades at prices ranging from $87.13 to $88.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F10: This transaction was executed in multiple trades at prices ranging from $88.19 to $88.34. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.